Article type: Letter to Editor
Article
title: Oromandibular dystonia and botulinum neurotoxin: an overview
Journal: Medical
Journal of Dr. D.Y. Patil Vidyapeeth
Year: 2019
Authors: Jamir Pitton Rissardo, Ana Letícia Fornari
Caprara
E-mail: jamirrissardo@gmail.com
ABSTRACT
Albanese et al. in 2013 defined dystonia as a movement disorder with sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both. In this context, OMD is a type of focal dystonia involving the mouth, jaw, and tongue causing involuntary jaw closure or opening, deviation of the jaw, facial grimacing, and tongue movements. We would like to address two recent systematic reviews with botulinum toxin (BoNT) in the management of OMD, which we think that together with the study of Shailaja et al. could lead to a better understanding of the treatment of this disorder.
Keywords: Dystonia, botox, movement disorder, oromandibular, botulinum toxin
Full text available
at:
DOI
10.4103/mjdrdypu.mjdrdypu_254_19
Citation
Rissardo JP, Fornari Caprara AL. Oromandibular dystonia and botulinum neurotoxin: an overview. Med
J DY Patil Vidyapeeth 2019;12:554-5
